drugset / Trial / NCT04931004
Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
Phase 0
Completed
34 enrolled
Rutgers, The State University of New Jersey
Colgate Palmolive · collabUniversity of Leicester · collab
NaSequentialOpen-labelPrevention
Summary
Prospective, cross-sectional study evaluating the effect of commercially available mouthwashes on expelled/exhaled SARS-CoV-2 viral load using face mask sampling.
Timeline
- Start
- 2021-07-21
- Primary completion
- 2022-05-24
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetylpyridinium | Small molecule | 0.075 % | Oral |